Oramed Pharmaceuticals (NASDAQ:ORMP) Shares Cross Below 200-Day Moving Average of $2.66

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

Related Keywords

,Oramed Pharmaceuticals Trading ,Tower Research Capital ,Oramed Pharmaceuticals Inc ,Nasdaq ,Hedge Funds Weigh In On Oramed Pharmaceuticals ,Sigma Securities ,Invesco Ltd ,News Ratings For Oramed Pharmaceuticals Daily ,Renaissance Technologies ,Qube Research Technologies Ltd ,Oramed Pharmaceuticals ,Get Free Report ,Technologies Ltd ,Research Capital ,Pharmaceuticals Inc ,Oramed Pharmaceuticals Daily ,